Mural Oncology (MURA)
AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
3.73
-0.10 (-2.61%)
At close: Jan 29, 2025, 3:59 PM
3.72
-0.27%
After-hours Jan 29, 2025, 04:00 PM EST
Income Statement (Annual)
Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
Year | FY23 | FY22 | FY21 |
Revenue | n/a | n/a | n/a |
Cost of Revenue | 2.57M | 1.54M | 1.47M |
Gross Profit | -2.57M | -1.54M | -1.47M |
Operating Income | -194.64M | -195.15M | -175.37M |
Interest Income | n/a | n/a | n/a |
Pretax Income | -195.29M | -195.15M | -175.37M |
Net Income | -207.45M | -200.03M | -175.43M |
Selling & General & Admin | 30.04M | 25.08M | 15.55M |
Research & Development | 162.03M | 170.07M | 159.82M |
Other Expenses | n/a | n/a | n/a |
Operating Expenses | 192.07M | 195.15M | 175.37M |
Interest Expense | n/a | n/a | n/a |
Selling & Marketing Expenses | -667.00K | n/a | n/a |
Cost & Expenses | 194.64M | 195.15M | 175.37M |
Income Tax | 12.16M | 4.88M | 68.00K |
Shares Outstanding (Basic) | 16.69M | 16.69M | 16.69M |
Shares Outstanding (Diluted) | 16.69M | 16.69M | 16.69M |
EPS (Basic) | -12.43 | -11.99 | -10.51 |
EPS (Diluted) | -12.43 | -11.99 | -10.51 |
EBITDA | -192.72M | -183.38M | -173.89M |
Depreciation & Amortization | 2.57M | 1.54M | 1.47M |